Literature DB >> 30316069

Brain MRI findings in children and adolescents with Fabry disease.

C Marchesoni1, E Cisneros2, P Pfister3, P Yáñez3, C Rollan3, C Romero3, I Kisinovsky4, L Rattagan2, L León Cejas2, A Pardal2, G Sevlever3, R Reisin2.   

Abstract

OBJECTIVE: To evaluate the presence of white matter and hemorrhagic lesions in brain MRI of children and adolescents with Fabry disease (FD).
METHODS: Brain MRI studies in 44 consecutive children and teenagers (20 boys, mean age 14.6 years, range 7-21 years) were evaluated using classic sequences as well as, GRE-weighted images, for white matter lesions (WML) and chronic microbleed detection. All patients lacked history of stroke or TIA. Brain MRI findings in 46 consecutive children and adolescents without FD, referred for the evaluation of headaches (36 females, mean age 14.1 years, range 7-21 years) were evaluated as a control group. Additionally, we assessed the clinical manifestations of FD.
RESULTS: Seven children (15.9%) with FD had brain MRI evidence of asymptomatic WML (5 girls, mean age 14.8 years, range: 13-20 years) compared with 3 children (6.5%) in the control group (p = 0.01). Brain abnormalities in patients with FD revealed WML, deep gray matter and infratentorial involvement. Three patients presented two lesions each. None of the children showed microbleeds. Regarding clinical manifestations, 90.9% of the patients had signs or symptoms of FD.
CONCLUSION: We identified asymptomatic white matter brain lesions in 15.9% of children with FD without clinical history of stroke. FD is a treatable disorder that should be routinely included in the differential diagnosis of both symptomatic and asymptomatic brain lesions in children and adolescents. The detection of brain lesions may foster earlier treatment.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Childhood; Lysosomal; Stroke; Vascular lesions; White matter

Mesh:

Year:  2018        PMID: 30316069     DOI: 10.1016/j.jns.2018.10.009

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

Review 1.  Clinical Characteristics, Renal Involvement, and Therapeutic Options of Pediatric Patients With Fabry Disease.

Authors:  Carmen Muntean; Iuliana Magdalena Starcea; Cristina Stoica; Claudia Banescu
Journal:  Front Pediatr       Date:  2022-06-01       Impact factor: 3.569

2.  Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis.

Authors:  R C Reisin; P Rozenfeld; P Bonardo
Journal:  Med Hypotheses       Date:  2020-09-17       Impact factor: 1.538

3.  Prevalence of cerebral small vessel disease in a Fabry disease cohort.

Authors:  Daisy Tapia; David Floriolli; Eric Han; Grace Lee; Annlia Paganini-Hill; Stephani Wang; Setarah Zandihaghighi; Virginia Kimonis; Mark Fisher
Journal:  Mol Genet Metab Rep       Date:  2021-10-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.